EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 Net Product Revenues

NEXT STORY
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
PREV STORY
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clinical Microbiology Market Value Anticipated To Reach US$ 6.5 Bn By 2027: Impact of COVID-19 on the Market

author_avatar
NASDAQ Market News

Cios Flow Mobile C-Arm Market Value Predicted To Reach US$ 4,676.5 Million By 2027 Covering Pre And Post COVID-19 Market Analysis: Acumen Research And Consulting

author_avatar
NASDAQ Market News

Sorrento Announces That Intranasal Administration of COVI-AMG™ Neutralizing Antibody Prevented COVID-19 Disease Progression in Infected Hamsters Following SARS-CoV-2 Infection

author_avatar
NASDAQ Market News